389 related articles for article (PubMed ID: 37798480)
21. Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis.
Chen H; Chengalvala V; Hu H; Sun D
Acta Pharm Sin B; 2021 Aug; 11(8):2136-2149. PubMed ID: 34522581
[TBL] [Abstract][Full Text] [Related]
22. Melanoma-derived exosomes: Versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma.
Alia Moosavian S; Hashemi M; Etemad L; Daneshmand S; Salmasi Z
Int Immunopharmacol; 2022 Dec; 113(Pt A):109320. PubMed ID: 36274482
[TBL] [Abstract][Full Text] [Related]
23. How cancer cells dictate their microenvironment: present roles of extracellular vesicles.
Naito Y; Yoshioka Y; Yamamoto Y; Ochiya T
Cell Mol Life Sci; 2017 Feb; 74(4):697-713. PubMed ID: 27582126
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy.
Liu H; Chen L; Peng Y; Yu S; Liu J; Wu L; Zhang L; Wu Q; Chang X; Yu X; Liu T
Oncotarget; 2018 Jan; 9(2):2887-2894. PubMed ID: 29416821
[TBL] [Abstract][Full Text] [Related]
25. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Vesicles and Their Roles in Cancer Progression.
Chang WH; Cerione RA; Antonyak MA
Methods Mol Biol; 2021; 2174():143-170. PubMed ID: 32813249
[TBL] [Abstract][Full Text] [Related]
27. Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment.
Rasihashemi SZ; Sahrai H; Rezazadeh-Gavgani E; Yazdani Y; Khalaji A; Lotfinejad P
Med Oncol; 2022 Sep; 39(12):183. PubMed ID: 36071295
[TBL] [Abstract][Full Text] [Related]
28. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes).
Whiteside TL
Biochem Soc Trans; 2013 Feb; 41(1):245-51. PubMed ID: 23356291
[TBL] [Abstract][Full Text] [Related]
29. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.
Naseri M; Bozorgmehr M; Zöller M; Ranaei Pirmardan E; Madjd Z
Oncoimmunology; 2020 Jun; 9(1):1779991. PubMed ID: 32934883
[TBL] [Abstract][Full Text] [Related]
30. Current theranostic approaches for metastatic cancers through hypoxia-induced exosomal packaged cargo.
Singh M; Agarwal S; Agarwal V; Mall S; Pancham P; Mani S
Life Sci; 2021 Dec; 286():120017. PubMed ID: 34619169
[TBL] [Abstract][Full Text] [Related]
31. Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology.
Yokoi A; Ochiya T
Semin Cancer Biol; 2021 Sep; 74():79-91. PubMed ID: 33798721
[TBL] [Abstract][Full Text] [Related]
32. Tumor-derived exosomes: immune properties and clinical application in lung cancer.
Wu J; Li S; Zhang P
Cancer Drug Resist; 2022; 5(1):102-113. PubMed ID: 35582534
[TBL] [Abstract][Full Text] [Related]
33. Exosomes in cancer development.
Stefanius K; Servage K; Orth K
Curr Opin Genet Dev; 2021 Feb; 66():83-92. PubMed ID: 33477017
[TBL] [Abstract][Full Text] [Related]
34. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W
J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872
[TBL] [Abstract][Full Text] [Related]
35. Exosomes and other extracellular vesicles in oral and salivary gland cancers.
Zhan C; Yang X; Yin X; Hou J
Oral Dis; 2020 Jul; 26(5):865-875. PubMed ID: 31390111
[TBL] [Abstract][Full Text] [Related]
36. Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy?
Martellucci S; Orefice NS; Angelucci A; Luce A; Caraglia M; Zappavigna S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899898
[TBL] [Abstract][Full Text] [Related]
37. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment.
Tian X; Shen H; Li Z; Wang T; Wang S
J Hematol Oncol; 2019 Aug; 12(1):84. PubMed ID: 31438991
[TBL] [Abstract][Full Text] [Related]
38. Emerging Significance and Therapeutic Potential of Extracellular vesicles.
Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q
Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688
[TBL] [Abstract][Full Text] [Related]
39. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.
Guo D; Chen Y; Wang S; Yu L; Shen Y; Zhong H; Yang Y
Immunology; 2018 May; 154(1):132-143. PubMed ID: 29197065
[TBL] [Abstract][Full Text] [Related]
40. Platelets Extracellular Vesicles as Regulators of Cancer Progression-An Updated Perspective.
Żmigrodzka M; Witkowska-Piłaszewicz O; Winnicka A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
